Pergolide:: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS).: Longterm follow up on pergolide -: Short communication

被引：26

作者：

Staedt, J ^{[1
]}

Hünerjäger, H ^{[1
]}

Rüther, E ^{[1
]}

Stoppe, G ^{[1
]}

机构：

[1] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany

来源：

JOURNAL OF NEURAL TRANSMISSION | 1998年 / 105卷 / 2-3期

关键词：

restless legs syndrome; RLS; nocturnal myoclonus syndrome; NMS; pergolide; longterm treatment;

D O I：

10.1007/s007020050055

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good effects after averagely 517 treatment days.

引用

页码：265 / 268

页数：4

共 12 条

[1] Augmentation of the restless legs syndrome with carbidopa/levodopa
Allen, RP
Earley, CJ
[J]. SLEEP, 1996, 19 (03) : 205 - 213
[2] ASKENASY JJM, 1984, J NEURAL TRANSM, V70, P151
[3] BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[4] CONTINUOUS AND INTERMITTENT LEVODOPA DIFFERENTIALLY AFFECT ROTATION INDUCED BY D-1 AND D-2 DOPAMINE AGONISTS
ENGBER, TM
SUSEL, Z
JUNCOS, JL
CHASE, TN
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 168 (03) : 291 - 298
[5] CONTINUOUS AND INTERMITTENT LEVODOPA DIFFERENTIALLY AFFECT BASAL GANGLIA FUNCTION
JUNCOS, JL
ENGBER, TM
RAISMAN, R
SUSEL, Z
THIBAUT, F
PLOSKA, A
AGID, Y
CHASE, TN
[J]. ANNALS OF NEUROLOGY, 1989, 25 (05) : 473 - 478
[6] NOCTURNAL MYOCLONUS - TREATMENT EFFICACY OF CLONAZEPAM AND TEMAZEPAM
MITLER, MM
BROWMAN, CP
MENN, SJ
GUJAVARTY, K
TIMMS, RM
[J]. SLEEP, 1986, 9 (03) : 385 - 392
[7] MONTI JM, 1988, PSYCHOPHARMACOLOGY, V95, P395
[8] Rechtschafen A., 1968, MANUAL STANDARDIZED
[9] Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): Two case reports
Staedt, J
Stoppe, G
Riemann, H
Hajak, G
Ruther, E
Riederer, P
[J]. JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (03) : 355 - 361
[10] SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET) IMAGING OF DOPAMINE D-2 RECEPTORS IN THE COURSE OF DOPAMINE REPLACEMENT THERAPY IN PATIENTS WITH NOCTURNAL MYOCLONUS SYNDROME (NMS)
STAEDT, J
STOPPE, G
KOGLER, A
RIEMANN, H
HAJAK, G
MUNZ, DL
EMRICH, D
RUTHER, E
[J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1995, 99 (1-3) : 187 - 193

← 1 2 →